IO Biotech Balance Sheet Health
Financial Health criteria checks 6/6
IO Biotech has a total shareholder equity of $133.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $150.7M and $17.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$143.19m |
| Equity | US$133.16m |
| Total liabilities | US$17.56m |
| Total assets | US$150.72m |
Recent financial health updates
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 10
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jun 15We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jan 20We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Sep 27We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Jun 14We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 25Recent updates
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 10We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jun 15We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jan 20IO Biotech names new CFO
Oct 13We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Sep 27IO Biotech GAAP EPS of -$0.64
Aug 11We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Jun 14We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 25Financial Position Analysis
Short Term Liabilities: IOBT's short term assets ($147.3M) exceed its short term liabilities ($15.7M).
Long Term Liabilities: IOBT's short term assets ($147.3M) exceed its long term liabilities ($1.8M).
Debt to Equity History and Analysis
Debt Level: IOBT is debt free.
Reducing Debt: IOBT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IOBT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: IOBT has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 42.6% each year.